Salomon & Ludwin’s Nuvalent NUVL Stock Holding History

Salomon & Ludwin’s Portfolio NUVL Stock Details NUVL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.78K	Hold	71	–	–	﹤0.01%	1643
2026 Q1	$7.49K	Hold	71	–	–	﹤0.01%	1633
2025 Q4	$6.95K	Hold	71	–	–	﹤0.01%	1640
2025 Q3	$5.98K	Buy	+71	New	+$5.61K	﹤0.01%	1635

Other funds holding NUVL

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

Salomon & Ludwin's NUVL Position: Q2 2026 in Review

Salomon & Ludwin held its Nuvalent (NUVL) position steady in Q2 2026 at 71 shares worth $8.78K. The position accounts for ﹤0.01% of the portfolio, ranked #1643.

Salomon & Ludwin first reported a position in NUVL in Q3 2025 and has held it in 4 quarters since. 293 funds tracked by Wall St. Rank hold NUVL as of Q2 2026.

Salomon & Ludwin held 71 shares of Nuvalent worth $8.78K as of Q2 2026.
Salomon & Ludwin left its Nuvalent share count unchanged in Q2 2026.
Nuvalent made up ﹤0.01% of Salomon & Ludwin's portfolio in Q2 2026, its #1643 holding.
Salomon & Ludwin first reported a position in Nuvalent in Q3 2025 and has held it in 4 quarters since.
293 funds tracked by Wall St. Rank held Nuvalent as of Q2 2026.

Based on Salomon & Ludwin's 13F filing for Q2 2026, filed 7 Aug 2026.